Unique ID issued by UMIN | UMIN000016486 |
---|---|
Receipt number | R000016189 |
Scientific Title | Exploratory human PET study with 11C-(S)ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes for Alzheimer's disease |
Date of disclosure of the study information | 2015/02/09 |
Last modified on | 2016/02/09 09:30:52 |
Exploratory human PET study with 11C-(S)ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes for Alzheimer's disease
KET-3
Exploratory human PET study with 11C-(S)ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes for Alzheimer's disease
KET-3
Japan |
Alzheimer's disease, Mild cognitive impairment, healthy
Psychiatry | Radiology | Adult |
Others
NO
Exploratory human PET study of the safety and the effectiveness of [11C](S)ketoprofen methyl ester as a potential biomarker of neuroinflammatory process for Alzheimer's disease
Safety,Efficacy
Exploratory
Retention and uptake of [11C](S)ketoprofen methyl ester in patients with Alzheimer's disease
Interventional
Parallel
Non-randomized
Open -no one is blinded
No treatment
3
Diagnosis
Medicine |
The dosage in the vein of [11C] ketoprofen methylester for PET imaging.
The dosage in the vein of [11C] ketoprofen methylester for PET imaging.
The dosage in the vein of [11C] ketoprofen methylester for PET imaging.
20 | years-old | <= |
99 | years-old | > |
Male and Female
Step1
1. The subject who has intention to participate in this study, and singed informed consent.
2. Age >=20 and <45 years old, with body weight >=50kgt and <85kg, and BMI >=17.6 and <26.4.
3. The subject who was judged by clinical investigator by means of physical examination and Laboratory tests to be eligible as a participant in this study.
Step2
1. The subject who has intention to participate in this study, and singed informed consent.
2. Age >=55 years old, body weight >=50kgt and <85kg, and BMI >=17.6 and <26.4.
3. The subject who was judged by clinical investigator by means of physical examination and Laboratory tests to be eligible as a participant in this study.
4.In healthy subjects, MRI findings is age-appropriate normal or there is no change to be a clinical problem.
In patients, subjects who do not have disease that causes cognitive impairment except MCI and AD by MRI.
1)The subject who has a peptic ulcer.
2)The subject who has blood abnormality.
3)The subject who has dysfunction in the liver / kidney.
4)The subject who has cerebrovascular disorder.
5)The subject having cardiac failure.
6)The subject with WPW or LGL syndrome, or marked bradycardia, in electrocardiogram.
7)The subject with a history of a drug or food allergy.
8)The subject who was judged by the clinical investigator to be inappropriate as a participant in this study.
21
1st name | |
Middle name | |
Last name | Michio Senda |
Institute of Biomedical Research and Innovation
Division of Molecular Imaging
2-2, Minatojima minamimachi, chuo-ku, Kobe, Hyogo
078-304-5212
senda@fbri.org
1st name | |
Middle name | |
Last name | Akihito Ohnishi |
Institute of Biomedical Research and Innovation
Division of Molecular Imaging
2-2, Minatojima minamimachi, chuo-ku, Kobe, Hyogo
078-304-5212
ohnishi@fbri.org
Institute of Biomedical Research and Innovation
Japan Science and Technology Agency
RIKEN
Kobe University
NO
公益財団法人先端医療振興財団 先端医療センター (兵庫県)
2015 | Year | 02 | Month | 09 | Day |
Unpublished
Completed
2014 | Year | 02 | Month | 07 | Day |
2014 | Year | 04 | Month | 30 | Day |
2015 | Year | 11 | Month | 30 | Day |
2015 | Year | 11 | Month | 30 | Day |
2015 | Year | 02 | Month | 09 | Day |
2016 | Year | 02 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016189
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |